A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy

Diagn Microbiol Infect Dis. 2020 Sep;98(1):115080. doi: 10.1016/j.diagmicrobio.2020.115080. Epub 2020 May 15.

Abstract

The objective of this study was to utilize a co-culture hollow-fiber infection model (HFIM) to characterize the interplay between a small, difficult-to-detect, New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae (NDM-Kp) minor population and a larger K. pneumoniae carbapenemase (KPC)-producing K. pneumoniae population in the presence of KPC-directed antibacterial therapy. Selective plating onto agar with ceftazidime-avibactam was used to track the density of the NDM-Kp population. Susceptibility testing and the Verigene System failed to identify the small initial NDM-Kp population. However, a ceftazidime-avibactam Etest detected resistant colonies that were confirmed to be NDM-Kp. In the HFIM, all of the investigated drug regimens caused regrowth within 24 h and resulted in >109 CFU/mL of NDM-Kp. Our study demonstrates that the HFIM is a powerful tool for studying the population dynamics of multiple pathogens during antimicrobial exposure and also highlights that difficult-to-detect minor populations of drug-resistant bacteria may cause treatment failure without appropriate antibacterial therapy.

Keywords: Ceftazidime-avibactam; Hollow fiber infection model; Klebsiella pneumoniae; Polymicrobial; Rapid diagnostics.

MeSH terms

  • Azabicyclo Compounds / pharmacology
  • Bacterial Proteins / pharmacology
  • Ceftazidime / pharmacology
  • Drug Combinations
  • Humans
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / growth & development*
  • Microbial Sensitivity Tests / methods*
  • Microbial Viability
  • beta-Lactamases / pharmacology*

Substances

  • Azabicyclo Compounds
  • Bacterial Proteins
  • Drug Combinations
  • avibactam, ceftazidime drug combination
  • Ceftazidime
  • beta-Lactamases
  • beta-lactamase NDM-1
  • carbapenemase